Portfolio Companies News
February 12, 2020Change in the management team
Lund, Sweden, 17:00 PM CET, 12 February 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries announces a change in its management team. Patrick O'Donnell will leave BONESUPPORT and his role as General Manager & Executive Vice President Commercial ... read more
January 31, 2020BONESUPPORT HOLDING AB signs an agr...
Lund, Sweden, 12:00 pm CET, 31 January 2020 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, today announced that the company has signed an agreement with Skandinaviska Enskilda Banken (SEB) for a credit facility of up to SEK 60 million. The credit line ... read more
January 30, 2020Aprea Therapeutics Receives FDA Bre...
BOSTON, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (NASDAQ: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein p53, today announced that the U.S. Food and Drug Administration (FD... read more
January 30, 2020Q4 incl. Full Year Report 2019
Strong fundamentals in place to fuel strategy for future growth Q4 2019 highlights Total net revenues of SEK 238.1 million (227.1), up 4.8 percent Zubsolv® US net revenues of SEK 190.5 million (166.7), up 14.3 percent in SEK and 7.5 percent in local currency Net earnings of SEK 38... read more
January 29, 2020Promising results from human PK stu...
OX338 demonstrated improved bioavailability and tolerability compared to commercially available reference product Further work required to optimise product formulation Uppsala, Sweden – January 29, 2020. Orexo AB (publ.) today announces promising results from its OX338 pharmacokinetic... read more
October 31, 2019Q3 2019 General Market Overview
Since the start in 1996, HealthCap funds have invested in 114 portfolio companies.
43 of the portfolio companies have been taken public on nine different markets.
25 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.